Literature DB >> 9696005

Liver transplantation for adult polycystic liver disease.

K Swenson1, P Seu, M Kinkhabwala, M Maggard, P Martin, J Goss, R Busuttil.   

Abstract

Polycystic liver disease, commonly associated with polycystic kidney disease, can result in massive hepatomegaly and debilitating symptoms. Surgical intervention for symptomatic polycystic liver disease has been associated with significant morbidity and inconsistent long-term palliation; it is more appropriate in patients with a single dominant cyst or cysts which is/are confined to one lobe. At our institution, nine patients have undergone orthotopic liver transplantation for symptomatic hepatic cysts with excellent long-term results and minimal morbidity and mortality. Surgical candidates were selected based on severe limitations in daily activities and on sequelae of hepatic cystic involvement. Other factors considered were the extent and pattern of hepatic cystic disease, the degree of hepatic and renal dysfunction, and prior surgical intervention. Three patients (33%) required combined liver and kidney transplantation because of renal cystic involvement with renal insufficiency. The one-year survival rate was 89% with excellent symptomatic relief and improved quality of life in all the surviving patients. One death occurred in a significantly malnourished 62-year-old female. Complications included one case each of hepatic artery thrombosis requiring retransplantation, biliary leak necessitating biliary reconstruction, and postoperative bleeding requiring re-exploration. The mean hospital stay was 23 days and the mean intraoperative blood transfusion requirement was 18 units. Our experience demonstrates that appropriately selected patients with extensive hepatic involvement with adult polycystic liver disease can have an excellent outcome with transplantation, with morbidity comparable with other surgical options.

Entities:  

Mesh:

Year:  1998        PMID: 9696005     DOI: 10.1002/hep.510280218

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

1.  Hepatic Cysts.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  Combined hepatic resection with fenestration for highly symptomatic polycystic liver disease: A report on seven patients.

Authors:  Guang-Shun Yang; Qi-Gen Li; Jun-Hua Lu; Ning Yang; Hai-Bin Zhang; Xue-Ping Zhou
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

3.  Laparoscopic palliation of polycystic liver disease.

Authors:  T N Robinson; G V Stiegmann; G T Everson
Journal:  Surg Endosc       Date:  2004-11-11       Impact factor: 4.584

Review 4.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 5.  Management of polycystic liver disease.

Authors:  Gregory T Everson; Matthew R G Taylor
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 6.  Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Authors:  Luiz Fernando Norcia; Erika Mayumi Watanabe; Pedro Tadao Hamamoto Filho; Claudia Nishida Hasimoto; Leonardo Pelafsky; Walmar Kerche de Oliveira; Ligia Yukie Sassaki
Journal:  Hepat Med       Date:  2022-09-29

Review 7.  Surgical management of polycystic liver disease.

Authors:  Robert T Russell; C Wright Pinson
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

8.  Treatment of polycystic liver disease with resection-fenestration and a new classification.

Authors:  Tuan-Jie Li; Hai-Bin Zhang; Jun-Hua Lu; Jun Zhao; Ning Yang; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

9.  Laparoscopic treatment of biliary hepatic cysts: short- and medium-term results.

Authors:  Vincenzo Neri; Antonio Ambrosi; Alberto Fersini; Tiziano Pio Valentino
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

10.  Inferior vena cava stenting: a safe and effective treatment for intractable ascites in patients with polycystic liver disease.

Authors:  Jayleen Grams; Swee H Teh; Vicente E Torres; James C Andrews; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.